caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1902849805

Jason MelearM.D.

Medical OncologyAustin, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,988
Unique beneficiaries
—
Total services
36,059
Distinct HCPCS
53
Medicare payment
$586K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 393 Medical Oncology providers in TX — top quintile (cohort median 4,999).
REFERRAL NETWORK

Where Jason Melear's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 23 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
94889
ASCENSION SETON641,081
ASCENSION SETON60991
Pathologists Bio-Medical Laboratories Pllc
Clinical Laboratory · Coppell, TX
301,547
William Mcbroom
Family Practice · La Grange, TX
27280
Jerry Fain
Internal Medicine · Austin, TX
25346
Simon Trubek
Diagnostic Radiology · Austin, TX
23206
Daniel White
General Surgery · La Grange, TX
2082
John Manning
Diagnostic Radiology · Austin, TX
19106
Thomas Borgstedte
Family Practice · La Grange, TX
19154
NPI 118462691317120
Demetrius Loukas
Medical Oncology · Austin, TX
17860
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,006
Beneficiaries
—
Total drug cost
$6.5M
Distinct drugs
28
Brand share
56.4%
Top prescribed drugs
Lenalidomide111 claims
Hydroxyurea101 claims
Zanubrutinib75 claims
Acyclovir73 claims
Acalabrutinib Maleate55 claims
QUALITY · MIPS · 2024
Final MIPS score
85.1
Quality
67.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.43%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$42K
Payment records
66
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$37K
Food and Beverage$2K
Consulting Fee$2K
Travel and Lodging$1K
Education$62